Abstract

Objective: This study is to compare the clinical efficacy of percutaneous transhepatic balloon dilatation(PTBD)and endoscopic papillary balloon dilatation(EPBD) in treating common bile duct(CBD)stones. Methods: Between January 2013 and January 2015,a comparison study was conducted among 25 patients with CBD stones who underwent PTBD treatment and were listed in Group A while 60 patients who underwent EPBD treatment and were listed in Group B. Results: Clearance of CBD stones in Group A patients was 100% ,and 96.7% in group B (P=1.000), with no significant statistical difference. The average time of the procedure was (50±8) minutes and (39±6) minutes, respectively. The short-term incidence of complications in group A was 12%(3/25),and 10%(6/60)in Group B(P>0.05). However,one hepatic abscess occurred in group A and two cases of pancreatitis occurred in group B. A one-year follow-up study demonstrated one gallstone recurrence in group A and one cholangitis in group B. Conclusions: Percutaneous transhepatic removal of CBD stones has a high success rate with low complications . It is an effective alternative strategy for CBD treatment, especially when endoscopic procedure fails or is not feasible. Key words: Common bile duct stone; Percutaneous transhepatic removal of stone; Endoscopic papillary balloon dialatation

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.